Investigation of the effect of Selenium in beta thalassemia major

Phase 2

• Conditions: thalassemia major.; Beta thalassemia; D56.1

• Registration Number: IRCT20180603039959N3
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

Having thalassemia major or intermedia
Healthy liver and kidney function

Exclusion Criteria

Severe heart, liver or kidney failure
History of chemotherapy
Diabetic patients
Patients with fever and acute and chronic inflammatory infections
Taking any selenium supplement for at least two months before the study

Study & Design

• Study Type: interventional
• Study Design: Not specified